Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8PSY

ERK2 covelently bound to RU68 cyclohexenone based inhibitor

Summary for 8PSY
Entry DOI10.2210/pdb8psy/pdb
DescriptorMitogen-activated protein kinase 1, AMP PHOSPHORAMIDATE, ~{O}3-~{tert}-butyl ~{O}1-methyl (1~{S},3~{R})-4-oxidanylidene-1-(phenylmethyl)cyclohexane-1,3-dicarboxylate, ... (4 entities in total)
Functional Keywordsmapk kinase, mapk, inhibitor, covalent, erk2, michael acceptor warhead, signaling protein
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight42519.57
Authors
Sok, P.,Poti, A.,Remenyi, A.,Gogl, G. (deposition date: 2023-07-13, release date: 2024-07-24, Last modification date: 2024-10-16)
Primary citationPoti, A.L.,Balint, D.,Alexa, A.,Sok, P.,Ozsvath, K.,Albert, K.,Turczel, G.,Magyari, S.,Ember, O.,Papp, K.,Kiraly, S.B.,Imre, T.,Nemeth, K.,Kurtan, T.,Gogl, G.,Varga, S.,Soos, T.,Remenyi, A.
Targeting a key protein-protein interaction surface on mitogen-activated protein kinases by a precision-guided warhead scaffold.
Nat Commun, 15:8607-8607, 2024
Cited by
PubMed Abstract: For mitogen-activated protein kinases (MAPKs) a shallow surface-distinct from the substrate binding pocket-called the D(ocking)-groove governs partner protein binding. Screening of broad range of Michael acceptor compounds identified a double-activated, sterically crowded cyclohexenone moiety as a promising scaffold. We show that compounds bearing this structurally complex chiral warhead are able to target the conserved MAPK D-groove cysteine via reversible covalent modification and interfere with the protein-protein interactions of MAPKs. The electronic and steric properties of the Michael acceptor can be tailored via different substitution patterns. The inversion of the chiral center of the warhead can reroute chemical bond formation with the targeted cysteine towards the neighboring, but less nucleophilic histidine. Compounds bind to the shallow MAPK D-groove with low micromolar affinity in vitro and perturb MAPK signaling networks in the cell. This class of chiral, cyclic and enhanced 3D shaped Michael acceptor scaffolds offers an alternative to conventional ATP-competitive drugs modulating MAPK signaling pathways.
PubMed: 39366929
DOI: 10.1038/s41467-024-52574-1
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.55 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon